NCT06019897

Brief Summary

The objective of this study is to assess the relationship between infusion system colonization (ramps or multi-lumen devices) and the occurrence of CVC infection/colonization. This study is a prospective observational research that does not modify usual patient care. Its objective is to evaluate the relationship between infusion tubing colonization and the occurrence of central venous catheter colonization. The only additional intervention is swabbing the taps at each IV line ramp at systematic ramp changes (done every 4 days) and at catheter removal. For the multi-lumen device, swabbing is only performed upon catheter removal at the level of the one-way valves. After catheter removal, a flush (1 mL of 0.9% NaCl) of the midline is performed and cultured to assess for endoluminal colonization. The distal end of the CVC is sent for culture, following the usual practice of the department to monitor catheter colonization and infections. The primary outcome measure is the proportion of colonized infusion systems based on the culture of the CVC. The secondary objectives are to describe factors associated with CVC infections, to determine the incidence of colonization and infections in different locations of central venous catheters, to analyze the bacterial ecology based on the type of infusion system used, and to evaluate the ecological and economic impact of different devices (ramps vs. multi-lumen devices). The secondary outcome measures are as follows: Proportion of colonized infusion systems based on the colonization status of the CVC and the type of infusion system (ramps vs. multi-lumen devices) Proportion of colonized infusion systems based on the infection status of the CVC and the type of infusion system (ramps vs. multi-lumen devices) Duration of antibiotic treatment Weight of compounds used with each infusion system over the duration of CVC placement (ramps vs. multi-lumen devices) Calculation of material costs based on the infusion system used over the duration of CVC placement (ramps vs. multi-lumen devices)

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 31, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

October 23, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

October 6, 2023

Status Verified

August 1, 2023

Enrollment Period

1 year

First QC Date

May 25, 2023

Last Update Submit

October 4, 2023

Conditions

Keywords

Catheter related infectioncatheter colonization

Outcome Measures

Primary Outcomes (1)

  • Incidence of central venous catheter colonization according to the status colonized or not of the tubing

    catheter colonization is defined as a positive culture of the catheter tips ≥ 10p3 CFU/ml and compare the rates in catheter with or without a positive culture of tubiging systems

    up to Catheter removal or up to 6 weeks

Secondary Outcomes (4)

  • Number of days without antibiotics at Day 42 (in the ICU)

    up to Catheter removal or up to 6 weeks

  • Incidence of colonization and infection of central venous catheter according to their site

    up to Catheter removal

  • Incidence of central venous catheter colonization according to the colonization of tubing and to the use or not of a multi lumen device

    up to catheter removal or up to 6 weeks

  • Incidence of central venous catheter infection according to the tubing colonization

    up to catheter removal or up to 6 weeks

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients admitted in a surgical intensive care unit and requiring a central venous catheter for drug administration

You may qualify if:

  • Adults \> 18 years old
  • Admitted in Surgical Intensive Care unit
  • Requiring a central venous catheter for more than 48h for drug administration (central venous catheter for renal replacement therapy are excluded)

You may not qualify if:

  • Patients \< 18 years old
  • Patients under legal protection
  • Patients who refuse the use of their data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

We will swab the taps at each IV line ramp at systematic ramp changes (done every 4 days) and at catheter removal. For the multi-lumen device, swabbing is only performed upon catheter removal at the level of the one-way valves. After catheter removal, a flush (1 mL of 0.9% NaCl) of the midline is performed and cultured to assess for endoluminal colonization. The distal end of the CVC is sent for culture, following the usual practice of the department to monitor catheter colonization and infections. All these samples will be cultured on agar plates for microbial detection, quantification and identification.

MeSH Terms

Conditions

Catheter-Related Infections

Condition Hierarchy (Ancestors)

Infections

Study Officials

  • sigismond lasocki, MD, PhD

    CHU Angers, 49033 Angers Cedex 01, France

    STUDY DIRECTOR

Central Study Contacts

Maëva CAMPFORT, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2023

First Posted

August 31, 2023

Study Start

October 23, 2023

Primary Completion

November 1, 2024

Study Completion

January 1, 2025

Last Updated

October 6, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

no plan